Literature DB >> 10644359

Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates.

W Soong1, J C Schultz, A C Patera, M H Sommer, J I Cohen.   

Abstract

Varicella-zoster virus (VZV) disseminates in the body in peripheral blood mononuclear cells during chickenpox. Up to 1 in 10,000 mononuclear cells are infected during the viremic phase of the disease. We developed an in vitro system to infect human mononuclear cells with VZV by using umbilical cord blood. In this system, 3 to 4% of T cells were infected with VZV. VZV mutants unable to express certain genes, such as open reading frame 47 (ORF47) or ORF66, were impaired for growth in T cells, while other mutants showed little difference from parental virus. VZV unable to express ORF47 was even more impaired for spread from umbilical cord blood cells to melanoma cells in vitro. Early-passage clinical isolates of VZV infected T cells at a similar rate to the Oka vaccine strain; however, the clinical isolates were more efficient in spreading from infected T cells to melanoma cells. This in vitro system for infecting human T cells with VZV should be useful for identifying cellular and viral proteins that are important for virus replication in T cells and for the spread of virus from T cells to other cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644359      PMCID: PMC111664          DOI: 10.1128/jvi.74.4.1864-1870.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Lymphocyte-associated viremia in varicella.

Authors:  T Ozaki; T Ichikawa; Y Matsui; H Kondo; T Nagai; Y Asano; K Yamanishi; M Takahashi
Journal:  J Med Virol       Date:  1986-07       Impact factor: 2.327

2.  Growth properties of human herpesvirus-6 strain Z29.

Authors:  J B Black; K C Sanderlin; C S Goldsmith; H E Gary; C Lopez; P E Pellett
Journal:  J Virol Methods       Date:  1989-11       Impact factor: 2.014

3.  Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.

Authors:  C M Koropchak; S M Solem; P S Diaz; A M Arvin
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Severity of viremia and clinical findings in children with varicella.

Authors:  Y Asano; N Itakura; Y Kajita; S Suga; T Yoshikawa; T Yazaki; T Ozaki; K Yamanishi; M Takahashi
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

5.  Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.

Authors:  J I Cohen; K E Seidel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella.

Authors:  M H Sawyer; Y N Wu; C J Chamberlin; C Burgos; S K Brodine; W A Bowler; A LaRocco; E C Oldfield; M R Wallace
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

7.  Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro.

Authors:  J I Cohen; K E Seidel
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

8.  Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.

Authors:  C M Koropchak; G Graham; J Palmer; M Winsberg; S F Ting; M Wallace; C G Prober; A M Arvin
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

9.  Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.

Authors:  Y Hayakawa; S Torigoe; K Shiraki; K Yamanishi; M Takahashi
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

10.  Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture.

Authors:  E Cox; S Reddy; I Iofin; J I Cohen
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.513

View more
  37 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 2.  Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.

Authors:  Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases.

Authors:  Angela Erazo; Paul R Kinchington
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 5.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

6.  T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.

Authors:  Anne Schaap; Jean-Francois Fortin; Marvin Sommer; Leigh Zerboni; Shaye Stamatis; Chia-Chi Ku; Garry P Nolan; Ann M Arvin
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Simian varicella virus gene expression during acute and latent infection of rhesus macaques.

Authors:  Christine Meyer; Amelia Kerns; Alex Barron; Craig Kreklywich; Daniel N Streblow; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2011-11-04       Impact factor: 2.643

Review 8.  Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Authors:  Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.